Dexco valuation
R$6.81Change from previous close: +10.37%Absolute change: +R$0.64
Valuation
The average price target of 10 analysts is R$7.83.
Data as of October 5, 2026
Valuation multiples
- Market cap
- R$5.6B
- Enterprise value
- R$12.18B
- Forward P/E
- 11.2
- PEG
- 2.00
- Price/book
- 0.81
- Price/sales
- 0.66
- EV/EBITDA
- 6.43
- EV/revenue
- 1.44
Profitability and growth
- Gross margin
- 24.9%
- Operating margin
- 5.7%
- Net margin
- -0.4%
- ROE
- 0.7%
- ROA
- 2.5%
- ROIC
- 5.4%
- Revenue growth (year over year)
- 5.2%
Financial health
- Total cash
- R$2.68B
- Total debt
- R$8.77B
- Debt/equity
- 1.19
- Current ratio
- 1.98
- Quick ratio
- 1.35
- Altman Z-Score
- 1.11
- Piotroski F-Score
- 6.00
Dividends
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- R$7.83
- Median price target
- R$7.53
- High price target
- R$9.50
- Low price target
- R$5.80
- Analysts with a price target
- 10
- Consensus
- Strong buy
- Forward EPS
- R$0.55
- EPS estimate, current year
- R$0.34
Shares and trading
- Beta
- 0.37
- Average volume
- 1.92M
- Shares outstanding
- 907.87M
- Float
- 279.19M
- Institutional ownership
- 41.9%
- Insider ownership
- 51.0%